MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/02770903.2026.2706360

Медицинская библиотека · The Journal of asthma : official journal of the Association for the Care of Asthma · 2026

Cohort-based development and validation of a nomogram for predicting cough variant asthma progression to typical asthma in children.

Zheng Kaiwen, Wang Qin, Zhao Yuling, Li Jiayi, Chen Xing

СтатьяПеревод в очереди

Аннотация

UNLABELLED: Cough variant asthma (CVA) is a common precursor of typical asthma (TA) in pediatric populations, whereas prediction of the progression from childhood CVA to TA remains difficult in clinical practice. This study aimed to screen independent risk factors for the progression of pediatric CVA to TA and construct a visualized nomogram prediction model for early risk stratification of this disease progression.

METHODS

A prospective cohort of 289 children diagnosed with CVA between June 2023 and June 2024 was followed for 12 months until June 2025. Patients were randomly divided into a training set (n = 203) and a validation set (n = 86) in a 7:3 ratio. Predictors were screened by univariate logistic regression and LASSO regression. A nomogram was constructed using the rms package in R and evaluated by ROC curves, 1000-iteration Bootstrap calibration, decision curve analysis (DCA), and Hosmer-Lemeshow tests.

RESULTS

During the 12-month follow-up, 42 children (14.5%) progressed to TA. Ten independent predictors were finally selected by LASSO regression and incorporated into the nomogram: personal history of allergy (OR = 3.62, 95% CI:1.78-7.36), family history of asthma (OR = 3.18, 95% CI:1.37-7.39), poor treatment compliance (OR = 2.94, 95% CI:1.32-6.55), history of pet keeping (OR = 2.41, 95% CI: 1.11-5.24), FeNO (OR = 1.09, 95% CI:1.05-1.14), CaNO (OR = 1.16, 95% CI: 1.06-1.27), X5%pred (OR = 1.04, 95% CI:1.02-1.07), R5%pred (OR = 1.03, 95% CI:1.01-1.06), FEF25%pred (OR = 0.96, 95% CI:0.94-0.98), and MMEF%pred (OR = 0.97, 95% CI: 0.95-0.99). The nomogram showed good discrimination with AUCs of 0.863 (95% CI: 0.782-0.944) in the training set and 0.838 (95% CI:0.742-0.933) in the validation set. Hosmer-Lemeshow tests indicated good fit (training:χ2=6.7277, p = 0.5663; validation:χ2=7.7376, p = 0.4595). DCA demonstrated favorable clinical net benefit across a wide range of threshold probabilities.

CONCLUSIONS

This novel nomogram integrating ten key risk factors provides a preliminary and visually intuitive tool for risk stratification of CVA progression to TA in children.

Для цитирования: Zheng Kaiwen, Wang Qin, Zhao Yuling, Li Jiayi, Chen Xing. Cohort-based development and validation of a nomogram for predicting cough variant asthma progression to typical asthma in children.. The Journal of asthma : official journal of the Association for the Care of Asthma. 2026. DOI: 10.1080/02770903.2026.2706360.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.